Peptidase is a scientifically validated solution employed in patients suffering from chronic kidney disease (CKD), Protein-Energy Wasting (PEW) and Protein-Energy Malnutrition (PEM) in liver cirrhosis, and those with Cancer Cachexia. Its efficacy lies in enhancing nutritional indices, leading to an improved and active quality of life for individuals facing these health challenges.
Here’s how Peptidase sets itself apart in the realm of protein supplements with its unique approach to absorption and scientifically validated efficacy:
Explore the unique benefits that set Peptidase apart:
Ideal for patients with fluid, phosphorus, and potassium restrictions, as each 25gm sachet can be reconstituted with just 75 ml of water, containing minimal potassium and phosphorus.
Peptidase minimises dialysis recovery time and boasts an impressive 18-fold improvement in albumin turnover compared to other protein supplements on the market.
Yes. A clinical trial has definitively demonstrated its superiority over double the dosage of Whey Protein, with half the dosage of Peptidase. Clinical results indicate that the absorption and assimilation of protein from 3 sachets are equivalent to the protein content of 1 tin (400mg) of protein jars.
Reconstitute Enzotein (Peptidase) by mixing it with 75ml of water. Start by adding 25ml to create a paste, then gradually add an additional 50ml until it’s ready to drink.
Peptidase is infused with a subtle vanilla flavour, carefully dosed to minimise potential side effects associated with flavours high in phosphorus and potassium.
Peptidase is packaged in boxes containing 28 sachets and can be stored at room temperature.
Yes, Peptidase alone fulfils protein requirements. However, if patients require additional multivitamins and minerals, they should be taken separately.
Yes, the patent application for Peptidase was submitted in the year 2020.